Эндоскопиялық және лапароскопиялық оталардың маманы – доктор Коэн Ассута медициналық орталығында жатыр мойны обырын емдеудің аз инвазивті әдістерін ұсынады.
Онкогинекология саласындағы профессор және маман Гилад Бен Барух Ассута медициналық орталығында жатыр мойны обырын емдеуде өзінің терең тәжірибесін қолданады.
Онкология институты мен Сүт безі қатерлі ісігін емдеу орталығының басшысы – доктор Яблонски-Перец Хадасса медициналық орталығында жатыр мойны қатерлі ісігін емдеуде көпжылдық мамандандырылған тәжірибесімен бөліседі.
Акушерлік және гинекология бөлімінің меңгерушісі, профессор – доктор Энгель Нордвест клиникасында онкогинекология бойынша маманданған.
Герцлия медициналық орталығының гинекологиялық онкология саласындағы эндоскопиялық және лапароскопиялық оталарға маманданған жетекші онкогинекологы.
Проф. др. Адем Дервишоглу инвазивтілігі аз хирургиялық әдістерге маманданған және жатыр мойны обырын емдеуде озық тәжірибесін қолданады.
Доктор Купелиоглу акушерлік және гинекология саласында маманданған, сонымен қатар бедеулікті емдеу мен отбасын жоспарлау бойынша үлкен тәжірибесі бар.
Рамбам медициналық орталығының акушерлік, гинекология және онкогинекология саласындағы маманы. Жатыр мойны обырын емдеуге ерекше көңіл бөледі.
Доктор Залманова Ассута медициналық орталығында жатыр мойны обырын радиотерапиямен емдеуге маманданған.
Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.
She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.
She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.
Жатыр мойны обырын клиникалық зерттеулердің бас зерттеушісі — доктор Окнин Барселонадағы Кирон госпиталінде ангиогенез және ДНҚ репарациясы бойынша зерттеулерді басқарады.
Самсунг медициналық орталығында онкогинекология саласында маманданған — тек жатыр мойны обырын емдеуге бағытталған.
Доктор Ким Тхэ Джун — Самсунг медициналық орталығының білікті гинекологы және онкогинекологы.
Гинекология саласындағы 38 жылдық тәжірибе – Кристиан Кайнц жатыр мойны обырын емдеудегі лапароскопиялық және эндоскопиялық операцияларға маманданған.
Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).
She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).
Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.
Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).
Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.
He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.
Member: Egyptian Cancer Society, ESTRO, ESMO.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.